Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study).

Q1 Medicine
Minerva Urologica E Nefrologica Pub Date : 2020-10-01 Epub Date: 2020-01-07 DOI:10.23736/S0393-2249.19.03637-3
Alessandro Antonelli, Carlotta Palumbo, Marianna Noale, Walter Artibani, Pierfrancesco Bassi, Filippo Bertoni, Sergio Bracarda, Alessio Bruni, Renzo Corvò, Mauro Gacci, Stefano M Magrini, Rodolfo Montironi, Angelo Porreca, Andrea Tubaro, Vittorina Zagonel, Stefania Maggi
{"title":"Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study).","authors":"Alessandro Antonelli, Carlotta Palumbo, Marianna Noale, Walter Artibani, Pierfrancesco Bassi, Filippo Bertoni, Sergio Bracarda, Alessio Bruni, Renzo Corvò, Mauro Gacci, Stefano M Magrini, Rodolfo Montironi, Angelo Porreca, Andrea Tubaro, Vittorina Zagonel, Stefania Maggi","doi":"10.23736/S0393-2249.19.03637-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We assessed patients and tumor characteristics, as well as health-related quality of life (HRQoL) items, associated with curative intent treatment decision-making in clinically localized prostate cancer (PCa) patients.</p><p><strong>Methods: </strong>Clinically localized PCa treated with either radical prostatectomy (RP) or radiation therapy (RT) within 12 months from diagnosis were abstracted from The PROState cancer monitoring in ITaly, from the National Research Council (Pros-IT CNR) database. Multivariable logistic regression (MLR) models predicting RT vs. RP were fitted, after adjustment for HRQoL items, patients and tumor characteristics.</p><p><strong>Results: </strong>Of 1041 patients, 631 (60.2%) were treated with RP and 410 (39.8%) with RT. Relative to RT, RP patients were younger age (mean age 64.5±6.6 vs. 71.4±4.9, P<0.001) and had higher rates of D'Amico low-intermediate risk groups (31.8 vs. 21.9% low, 46.3% vs. 43.5% intermediate and 21.9% vs. 34.6% high risk, P<0.001). Overall, 93.2% of RP patients were enrolled by urologists and 82.7% of RT patients by radiation oncologists. RP patients had generally higher means values of HRQoL items. In MLR models, higher RT rates were independently associated with more advanced age (odds ratio [OR] 6.14, P<0.001) and BMI≥30 kg/m<sup>2</sup> (OR 1.78, P<0.001). Conversely, lower rates of RT were independently associated with married (OR 0.55, P=0.01) and worker status (OR 0.52, P=0.004), enrollment in academic centers (OR 0.59, P=0.005) and higher physical composite score (OR 0.88, P=0.03) and baseline sexual function items (OR 0.92, P<0.001).</p><p><strong>Conclusions: </strong>Most patients with clinically localized prostate cancer undergoing definitive treatment at Italian institutions receive RP instead of RT. Moreover, those who are younger, married, working, as well as those with better physical and sexual function are more likely to undergo surgery.</p>","PeriodicalId":49015,"journal":{"name":"Minerva Urologica E Nefrologica","volume":"72 5","pages":"595-604"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Urologica E Nefrologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0393-2249.19.03637-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We assessed patients and tumor characteristics, as well as health-related quality of life (HRQoL) items, associated with curative intent treatment decision-making in clinically localized prostate cancer (PCa) patients.

Methods: Clinically localized PCa treated with either radical prostatectomy (RP) or radiation therapy (RT) within 12 months from diagnosis were abstracted from The PROState cancer monitoring in ITaly, from the National Research Council (Pros-IT CNR) database. Multivariable logistic regression (MLR) models predicting RT vs. RP were fitted, after adjustment for HRQoL items, patients and tumor characteristics.

Results: Of 1041 patients, 631 (60.2%) were treated with RP and 410 (39.8%) with RT. Relative to RT, RP patients were younger age (mean age 64.5±6.6 vs. 71.4±4.9, P<0.001) and had higher rates of D'Amico low-intermediate risk groups (31.8 vs. 21.9% low, 46.3% vs. 43.5% intermediate and 21.9% vs. 34.6% high risk, P<0.001). Overall, 93.2% of RP patients were enrolled by urologists and 82.7% of RT patients by radiation oncologists. RP patients had generally higher means values of HRQoL items. In MLR models, higher RT rates were independently associated with more advanced age (odds ratio [OR] 6.14, P<0.001) and BMI≥30 kg/m2 (OR 1.78, P<0.001). Conversely, lower rates of RT were independently associated with married (OR 0.55, P=0.01) and worker status (OR 0.52, P=0.004), enrollment in academic centers (OR 0.59, P=0.005) and higher physical composite score (OR 0.88, P=0.03) and baseline sexual function items (OR 0.92, P<0.001).

Conclusions: Most patients with clinically localized prostate cancer undergoing definitive treatment at Italian institutions receive RP instead of RT. Moreover, those who are younger, married, working, as well as those with better physical and sexual function are more likely to undergo surgery.

前列腺癌根治术与放射治疗在临床局部前列腺癌治疗中的潜在决定因素概述:一项意大利前瞻性观察研究(Pros-IT CNR 研究)的结果。
背景:我们评估了与临床局部前列腺癌(PCa)患者治疗决策相关的患者和肿瘤特征以及健康相关生活质量(HRQoL)项目:我们评估了与临床局部前列腺癌(PCa)患者根治性治疗决策相关的患者和肿瘤特征以及健康相关生活质量(HRQoL)项目:方法:从意大利国家研究委员会(Pros-IT CNR)数据库的PROState癌症监测中摘录了诊断后12个月内接受根治性前列腺切除术(RP)或放射治疗(RT)的临床局部前列腺癌患者。在对 HRQoL 项目、患者和肿瘤特征进行调整后,建立了预测 RT 与 RP 的多变量逻辑回归(MLR)模型:在1041名患者中,631人(60.2%)接受了RP治疗,410人(39.8%)接受了RT治疗。与 RT 相比,RP 患者的年龄更小(平均年龄(64.5±6.6)岁 vs. 71.4±4.9),P2(OR 1.78,PConclusions:在意大利的医疗机构中,大多数接受明确治疗的临床局部前列腺癌患者接受的是 RP 而不是 RT。此外,年轻、已婚、有工作以及身体和性功能较好的患者更有可能接受手术治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Minerva Urologica E Nefrologica
Minerva Urologica E Nefrologica UROLOGY & NEPHROLOGY-
CiteScore
5.50
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: The journal Minerva Urologica e Nefrologica publishes scientific papers on nephrology and urology. Manuscripts may be submitted in the form of Minerva opinion editorials, editorial comments, original articles, video illustrated articles, review articles and letters to the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信